Welcome to LookChem.com Sign In|Join Free

CAS

  • or

74788-82-2

Post Buying Request

74788-82-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

74788-82-2 Usage

Uses

Different sources of media describe the Uses of 74788-82-2 differently. You can refer to the following data:
1. 2,6-Dimethylbenzylamine is an intermediate in the synthesis of flavin derivatives for therapeutic use as anti-infective agents.
2. 2,5-Dimethylbenzylamine is an intermediate in the synthesis of flavin derivatives for therapeutic use as anti-infective agents.

Check Digit Verification of cas no

The CAS Registry Mumber 74788-82-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,7,8 and 8 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 74788-82:
(7*7)+(6*4)+(5*7)+(4*8)+(3*8)+(2*8)+(1*2)=182
182 % 10 = 2
So 74788-82-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H13N/c1-7-4-3-5-8(2)9(7)6-10/h3-5H,6,10H2,1-2H3

74788-82-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-Dimethylbenzylamine

1.2 Other means of identification

Product number -
Other names (2,6-dimethylphenyl)methanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:74788-82-2 SDS

74788-82-2Relevant articles and documents

Compounds for the treatment of metabolic disorders

-

Page/Page column 106, (2016/03/12)

Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.

Compounds for the treatment of metabolic disorders

-

, (2008/06/13)

Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.

Novel isoxazole and isoxazoline compounds with anticonvulsant activity process for their preparation and therapeutic composition containing them

-

, (2008/06/13)

The object of the invention are anticonvulsant heterocyclic compounds of general formula: STR1 in which R1 and R2 is each selected from C1 -C4 alkyl, phenyl, benzyl, trifluoromethyl or halogen, R3 is

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 74788-82-2